Toshikiro Kimura

4.2k total citations
111 papers, 3.6k citations indexed

About

Toshikiro Kimura is a scholar working on Pharmaceutical Science, Oncology and Molecular Biology. According to data from OpenAlex, Toshikiro Kimura has authored 111 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pharmaceutical Science, 38 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Toshikiro Kimura's work include Advanced Drug Delivery Systems (40 papers), Drug Transport and Resistance Mechanisms (38 papers) and Drug Solubulity and Delivery Systems (32 papers). Toshikiro Kimura is often cited by papers focused on Advanced Drug Delivery Systems (40 papers), Drug Transport and Resistance Mechanisms (38 papers) and Drug Solubulity and Delivery Systems (32 papers). Toshikiro Kimura collaborates with scholars based in Japan, Egypt and New Zealand. Toshikiro Kimura's co-authors include Kazutaka Higaki, Ken‐ichi Ogawara, Hitoshi Sezaki, Yuji Kurosaki, Masateru Miyake, Masaaki Odomi, Hajime Toguchi, Hitoshi Sezaki, Naoki Kamada and T. Mukai and has published in prestigious journals such as Journal of Controlled Release, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Toshikiro Kimura

111 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshikiro Kimura Japan 30 1.7k 951 780 647 474 111 3.6k
Vincent H.L. Lee United States 39 2.3k 1.3× 1.8k 1.9× 789 1.0× 437 0.7× 251 0.5× 136 5.7k
Kazutaka Higaki Japan 37 2.0k 1.1× 1.3k 1.4× 756 1.0× 1.1k 1.7× 653 1.4× 167 5.0k
Kanji Takada Japan 39 2.7k 1.5× 1.1k 1.2× 698 0.9× 311 0.5× 228 0.5× 246 5.1k
Chang‐Koo Shim South Korea 38 1.9k 1.1× 1.4k 1.5× 898 1.2× 1.0k 1.6× 190 0.4× 181 4.8k
Hitoshi Sezaki Japan 31 1.3k 0.7× 1.3k 1.3× 932 1.2× 423 0.7× 140 0.3× 152 3.7k
Suk‐Jae Chung South Korea 35 1.3k 0.7× 2.0k 2.1× 777 1.0× 992 1.5× 200 0.4× 151 5.0k
Natalie L. Trevaskis Australia 30 2.9k 1.7× 1.5k 1.6× 1.1k 1.5× 609 0.9× 915 1.9× 84 5.8k
Teruko Imai Japan 30 989 0.6× 1.2k 1.2× 872 1.1× 236 0.4× 245 0.5× 147 4.4k
Panayiotis P. Constantinides United States 24 1.2k 0.7× 854 0.9× 361 0.5× 371 0.6× 237 0.5× 42 2.7k
Zhonggui He China 32 1.4k 0.8× 1.1k 1.1× 420 0.5× 1.0k 1.6× 513 1.1× 133 3.5k

Countries citing papers authored by Toshikiro Kimura

Since Specialization
Citations

This map shows the geographic impact of Toshikiro Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshikiro Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshikiro Kimura more than expected).

Fields of papers citing papers by Toshikiro Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshikiro Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshikiro Kimura. The network helps show where Toshikiro Kimura may publish in the future.

Co-authorship network of co-authors of Toshikiro Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Toshikiro Kimura. A scholar is included among the top collaborators of Toshikiro Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshikiro Kimura. Toshikiro Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogawara, Ken‐ichi, et al.. (2017). Development of Safe and Potent Oil-in-Water Emulsion of Paclitaxel to Treat Peritoneal Dissemination. Journal of Pharmaceutical Sciences. 106(4). 1143–1148. 9 indexed citations
2.
3.
Kono, Yusuke, et al.. (2011). PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. International Journal of Pharmaceutics. 412(1-2). 132–141. 122 indexed citations
4.
Kamada, Naoki, Keigo Yamada, Masaaki Odomi, et al.. (2011). Sex differences in pharmacokinetics of cilostazol in rats. Xenobiotica. 41(10). 903–913. 13 indexed citations
5.
Takanashi, Masashi, et al.. (2008). Effect of adrenergic stimulation on drug absorption via passive diffusion in Caco-2 cells. International Journal of Pharmaceutics. 368(1-2). 31–36. 13 indexed citations
6.
Ogawara, Ken‐ichi, et al.. (2007). Appearance of Double Peaks in Plasma Concentration–time Profile after Oral Administration Depends on Gastric Emptying Profile and Weight Function. Pharmaceutical Research. 25(4). 886–895. 58 indexed citations
7.
Ogawara, Ken‐ichi, et al.. (2007). Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug. International Journal of Pharmaceutics. 352(1-2). 36–43. 21 indexed citations
8.
Okuda, Tomoyuki, et al.. (2006). Involvement of intracellular Ca2+ dynamics in cytoprotective action by amino acids and cytotoxicity by sodium laurate, an absorption enhancer. Journal of Pharmaceutical Sciences. 95(10). 2256–2265. 16 indexed citations
9.
Miyake, Masateru, Naoki Kamada, Yoshikazu Oka, et al.. (2004). Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. Journal of Controlled Release. 99(1). 63–71. 21 indexed citations
10.
Ogawara, Ken‐ichi, et al.. (2004). Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. Journal of Controlled Release. 100(3). 451–455. 161 indexed citations
11.
Higaki, Kazutaka, et al.. (2004). Regulation of Drug Absorption from Small Intestine by Enteric Nervous System I: a Poorly Absorbable Drug Via Passive Diffusion. Drug Metabolism and Pharmacokinetics. 19(3). 198–205. 14 indexed citations
12.
Furumoto, Kentaro, Ken‐ichi Ogawara, Yoshinobu Takakura, et al.. (2004). Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor. Journal of Controlled Release. 97(1). 133–141. 39 indexed citations
13.
Yamashita, Kazunari, Toshiomi Nakate, Kazuto Okimoto, et al.. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. International Journal of Pharmaceutics. 267(1-2). 79–91. 295 indexed citations
14.
Ogawara, Ken‐ichi, et al.. (2003). Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model. Journal of Controlled Release. 86(2-3). 305–313. 18 indexed citations
15.
Ogawara, Ken‐ichi, et al.. (2002). Analysis and Prediction of Absorption Behavior for Theophylline Orally Administered as Powders Based on Gastrointestinal-transit-Absorption (Gita) Model. Drug Metabolism and Pharmacokinetics. 17(4). 307–315. 17 indexed citations
16.
Kimura, Toshikiro, Kazunari Sato, Katsuyoshi Sugimoto, et al.. (1996). Oral Administration of Insulin as Poly(Vinyl Alcohol)-Gel Spheres in Diabetic Rats.. Biological and Pharmaceutical Bulletin. 19(6). 897–900. 50 indexed citations
17.
18.
Kimura, Toshikiro, et al.. (1985). Absorption of 3-amino-1-methyl-5H-pyrido[4,3-b]indole, a mutagen-carcinogen present in tryptophan pyrolysate, from the gastro-intestinal tract in the rat.. PubMed. 76(4). 272–7. 6 indexed citations
19.
Sasaki, Hitoshi, et al.. (1983). Development of lipophilic prodrugs of mitomycin C. II. Stability and bioactivation of 1a-N-substituted derivatives with aromatic pro-moiety. International Journal of Pharmaceutics. 15(1). 61–71. 12 indexed citations
20.
Sasaki, Hitoshi, et al.. (1983). Development of lipophilic prodrugs of mitomycin C. I. Synthesis and antitumor activity of 1a-N-substituted derivatives with aromatic pro-moiety. International Journal of Pharmaceutics. 15(1). 49–59. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent H.L. Lee Breakdown of academic impact, for papers by Kazutaka Higaki Breakdown of academic impact, for papers by Kanji Takada Breakdown of academic impact, for papers by Chang‐Koo Shim Breakdown of academic impact, for papers by Hitoshi Sezaki Breakdown of academic impact, for papers by Suk‐Jae Chung Breakdown of academic impact, for papers by Natalie L. Trevaskis Breakdown of academic impact, for papers by Teruko Imai Breakdown of academic impact, for papers by Panayiotis P. Constantinides Breakdown of academic impact, for papers by Zhonggui He
Rankless by CCL
2026